Learn More
Medchemexpress LLC HYNIC-iPSMA TFA | 2375849-11-7 | 98.1% | 765.69 | 10 MG

Supplier: Medchemexpress LLC HYP5292A10MG
HYNIC-iPSMA TFA is a ligand designed for the molecular imaging of tumors. This compound is comprised of two key components: HYNIC (6-hydrazinonicotinamide) and iPSMA (Inhibitor of Prostate-Specific Membrane Antigen). HYNIC serves as a chemical linker, utilized for attaching radioactive isotopes to specific targeted molecules. iPSMA acts as a selective inhibitor, designed to target and inhibit prostate-specific membrane antigen (PSMA).
- Tumor molecular imaging.
- Component-based design.
- Radioactive isotope attachment.
- Prostate-specific membrane antigen inhibition.
- Prostate cancer detection.
- High specificity and sensitivity.
- Radionuclide-drug conjugate synthesis.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.